78 results on '"Lundberg, Ingrid E."'
Search Results
2. Polymyositis: does it really exist as a distinct clinical subset?
3. The EuroMyositis registry: an international collaborative tool to facilitate myositis research
4. Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study
5. Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
6. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
7. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
8. Recent clinical trials in idiopathic inflammatory myopathies
9. Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case–control study
10. Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case–control study
11. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria—methodological aspects
12. 08.10 Serum lipid and fatty acid profiles are altered in patients with polymyositis or dermatomyositis
13. 02.09 Identification of a novel pro-inflammatory T cell epitope from his-trna-synthetase associated with interstitial lung disease in anti-jo-1 positive patients
14. MYOSITIS IN 2016: New tools for diagnosis and therapy
15. Reply
16. Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases
17. Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies
18. Nitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness
19. An outsourced health-enhancing physical activity programme for people with rheumatoid arthritis: exploration of adherence and response
20. Differences and similarities in rheumatology specialty training programmes across European countries
21. Proteomic Profiling Reveals Autoimmune Targets in Sarcoidosis
22. Cardiomyopathy in Murine Models of Systemic Sclerosis
23. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease
24. Hand Exercise Intervention in Patients with Polymyositis and Dermatomyositis: A Pilot Study
25. Patients with regular physical activity before onset of rheumatoid arthritis present with milder disease
26. The skeletal muscle arachidonic acid cascade in health and inflammatory disease
27. Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up
28. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials
29. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy
30. Genome-Wide Association Study of Dermatomyositis Reveals Genetic Overlap With Other Autoimmune Disorders
31. Characterization Of Histidyl-tRNA Synthetase Specific Th Cell Response In Blood and Broncheoalveolar Lavage (BAL) Of Myositis Patients.: 2648
32. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis
33. Low serum levels of vitamin D in idiopathic inflammatory myopathies
34. Autoantibodies to cytosolic 5′-nucleotidase 1A in inclusion body myositis
35. Activated LTB4 pathway in muscle tissue of patients with polymyositis or dermatomyositis
36. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis
37. Persisting CD28null T cells, but not regulatory T cells, in muscle tissue of myositis patients after immunosuppressive therapy
38. IFN signature is associated with autoantibody profiles in patients with myositis
39. Anti-Ro52 epitope mapping in inflammatory myopathies
40. HMGB1 mediates muscle fatigue via TLR4 - a possible mechanism for muscle fatigue in patients with inflammatory myopathies
41. Crosstalk between nitrosative stress and altered Ca2+ handling in arthritis-induced skeletal muscle dysfunction
42. Effect of immunosuppressive treatment on gene expression in muscle from patients with polymyositis and dermatomyositis
43. The Role of TRAIL in Mediating Autophagy in Myositis Skeletal Muscle: A Potential Nonimmune Mechanism of Muscle Damage
44. Interrater reliability and aspects of validity of the myositis damage index
45. Pathogenesis, classification and treatment of inflammatory myopathies
46. Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study
47. Anakinra effects on T cells in patients with refractory idiopathic inflammatory myopathies
48. Receptors for B cell activating factor of the TNF Family (BAFF) are expressed in muscle tissue of myositis patients with anti–Jo-1 or anti–Ro 52/anti–Ro 60 autoantibodies and correlate with plasmacytoid dendritic cell markers
49. Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay
50. Expanded T cell receptor Vβ-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.